Patient preferences for psychiatric advance directives

International Journal of Forensic Mental Health

Volumn 5, Issue 1, 2006, Pages 67-81

  Swartz, Marvin S ^a   Swanson, Jeffrey W ^a   Van Dorn, Richard A ^a   Elbogen, Eric B ^a   Shumway, Martha ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46049084314     PISSN: 14999013     EISSN: 19329903     Source Type: Journal    
DOI: 10.1080/14999013.2006.10471231     Document Type: Article

References (37)

1. Amering, M., Stastny, P., & Hopper, K. (2005). Psychiatric advance directives: Qualitative study of informed deliberations by mental health service users. British Journal of Psychiatry, 186, 247-252.
2. Appelbaum, P. S. (2004). Psychiatric advance directives and the treatment of committed patients. Psychiatric Services, 55, 751-752.
3. Backlar P., McFarland B. H., Swanson J. W., & Mahler, J. (2001). Consumer, provider, and informal caregiver opinions on psychiatric advance directives. Administration of Policy and Mental Health, 28, 427-441.
4. Blair, J. R., & Spreen, O. (1989). Predicting premorbid IQ: A revision of the National Adult Reading Test. Clinical Neuropsychologist, 3, 129-136.
5. Dresser, R. (1984). Bound to treatment: The Ulysses contract. Hastings Center Report, 14, 13-16.
6. Endicott, J., Spitzer R. L., Fleiss J.L., & Cohen, J. (1976). The global assessment scale: A procedure for measuring overall severity of psychiatric disturbances. Archives of General Psychiatry, 33, 766-771.
7. Exworthy, T. (2004). Psychiatric advance decisions – an opportunity missed. Journal of Mental Health Law, Sept, 129-141.
8. Froberg, D. G., & Kane, R. L. (1989a). Methodology for measuring health-state preferences – I: Measurement strategies. Journal of Clinical Epidemiology, 42, 345-354
9. Froberg, D. G., & Kane, R. L. (1989b). Methodology for measuring health-state preferences – II: Scaling methods. Journal of Clinical Epidemiology, 42, 459-471.
10. Froberg, D. G., & Kane, R. L. (1989c). Methodology for measuring health-state preferences – III: Population and context effects. Journal of Clinical Epidemiology, 42, 585-592.
11. Froberg, D. G., & Kane, R. L. (1989d). Methodology for measuring health-state preferences – IV: Progress and a research agenda. Journal of Clinical Epidemiology, 42, 675-685.
12. Ganju, V. (1999). The MHSIP consumer survey. Austin, TX: Texas Department of MHMR.
13. Horvath, A. O., & Greenberg, L. (1989). Development and validation of the Working Alliance Inventory. Journal of Counseling Psychology, 36, 223-233.
14. Lee, T. T., Ziegler, J. K., Sommi, R., Sugar, C., Mahmoud, R., & Lenert, L. A. (2000). Comparison of preferences for health outcomes in schizophrenia among stakeholder groups. Journal of Psychiatric Research, 34, 201-210.
15. Lenert, L. A., Ziegler, J., Lee, T., Sommi, R., & Mahmoud, R. (2000). Differences in health values among patients, family members, and providers for outcomes in schizophrenia. Medical Care, 38, 1011-1021.
16. McEvoy J. P., Apperson L. J., Appelbaum, P. S., Ortlip, P., Brecosky, J., Hammill, K., Geller, J. L., & Roth, L. (1989). Insight in schizophrenia: Its relationship to acute psychopathology. Journal of Nervous and Mental Disease, 177, 43-47.
17. Moerner, M.G., Mannuzza, S., & Kane, J.M. (1988). Anchoring the BPRS: An aid to improved reliability. Psychopharmacology Bulletin, 24, 112-117.
18. Monahan, J., Redlich, A. D., Swanson, J., Robbins, P. C., Appelbaum, P. S., Petrila, J., Steadman, H. J., Swartz, M., Angell, B., & McNiel, D. E. (2005). Use of leverage to improve adherence to psychiatric treatment in the community. Psychiatric Services, 56, 37-44.
19. Neale, M. S., & Rosenheck, R. A. (1989). Therapeutic alliance and outcome in a VA intensive case management program. Psychiatric Services, 46, 719-721.
20. Noble, L. M., & Douglas, B. C. (2004). What users and relatives want from mental health services. Current Opinion in Psychiatry, 17, 289-296.
21. Revicki, D. A., Shakespeare, A., & Kind, P. (1996). Preferences for schizophrenia-related health states: A comparison of patients, caregivers and psychiatrists. International Journal of Clinical Psychopharmacology, 11, 101-108.
22. Rhoden, N. K. (1982). Commentary on Winston, M.E. and Winston, S.M. Can a subject consent to a “Ulysses contract?” Hastings Center Report, 12, 26-28.
23. Rosenheck, R. A, Stroup, S., Keefe, R., McEvoy, J., Swartz, M., Perkins, D., Hsaio, J., Shumway, M., & Lieberman, J. (2005). Measuring outcome priorities and incorporating preferences in mental health status assessment of people with schizophrenia. British Journal of Psychiatry, 187, 529-536.
24. Selzer, M. L. (1971). The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. American Journal of Psychiatry, 127, 1653-1658.
25. Shumway, M. (2003). Preference weights for cost-outcome analyses of schizophrenia treatments: Comparison for four stakeholder groups. Schizophrenia Bulletin, 29, 257-266.
26. Skinner, H. A. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7, 363–371.
27. Srebnik, D., Appelbaum, P. S., & Russo, J. (2004). Assessing competence to complete psychiatric advance directives with the competence assessment tool for psychiatric advance directives. Comprehensive Psychiatry, 45, 239-245.
28. Srebnik, D. S., Russo, J., Sage, J., Peto, T., & Zick E. (2003). Interest in psychiatric advance directives among high users of crisis services and hospitalization. Psychiatric Services, 54, 981-986.
29. Srebnik, D. S., Rutherford, L.T., Peto, T., Russo, J., Zick, E., Jaffe, C., & Holtzheimer, P. (2005). The content and clinical utility of psychiatric advance directives. Psychiatric Services, 56, 592–598.
30. Swanson, J. W., Swartz, M. S., Elbogen, E. B., Van Dorn, R. A., Ferron, J., Wagner, H. R., McCauley, B. J., & Kim, M. (under review). Facilitated psychiatric advance directives: A randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness.
31. Swanson, J. W., Swartz, M. S, Ferron, J., Elbogen, E. B., & Van Dorn, R. A. (2006). Psychiatric advance directives among public mental health patients in five U.S. cities: Prevalence, demand and correlates. Journal of the American Academy of Psychiatry and the Law, 34, 43-57.
32. Swanson, J. W, Swartz, M. S., Hannon, M. J., Elbogen, E. B., Wagner, H. R., McCauley, B. J., & Butterfield, M. I. (2003). Psychiatric advance directives: A survey of persons with schizophrenia, family members, and treatment providers. International Journal of Forensic Mental Health, 2, 73-86.
33. Swanson, J. W., Tepper, M. C., Backlar, P., & Swartz, M. S. (2000). Psychiatric advance directives: An alternative to coercive treatment? Psychiatry, 63, 160-172.
34. Swartz, M. S., Swanson, J. W., Ferron, J., Elbogen, E. B., Van Dorn, R., Kim, M., & Scheyett, A. (2005). Psychiatrists’ views and attitudes about psychiatric advance directives. International Journal of Forensic Mental Health, 4, 107-117.
35. Swartz, M. S., Wagner, H. R., Swanson, J. W., Hiday, V. A., & Burns, B. J. (2002). The perceived coerciveness of involuntary outpatient commitment: Findings from an experimental study. Journal of the American Academy of Psychiatry and the Law, 30, 207-217.
36. Swartz, M. S., Swanson, J. W., Wagner, H. R, Hannon, M. J., Burns, B. J., & Shumway, M. (2003). Assessment of four stakeholder groups’ preferences concerning outpatient commitment for persons with schizophrenia. American Journal of Psychiatry, 160, 1139-1146.
37. Tabachnick, B. G., & Fidell, L. S. (2001). Using multivariate statistics (4th ed.). Needham, MA: Allyn & Bacon.